HIK Hikma Pharmaceuticals Plc

TIDMHIK

RNS Number : 7335Z

Hikma Pharmaceuticals Plc

17 May 2023

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman and CEO 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Grant of a pledge by Darhold Limited over 1,000,000 
       transaction               Ordinary Shares of 10 pence each in Hikma Pharmaceuticals 
                                 PLC in favour Jordan Kuwait Bank. Darhold Limited 
                                 is defined as a Person Closely Associated with 
                                 the Executive Chairman and CEO, who is a director 
                                 and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,000,000 
 d)   Aggregated information    Aggregated volume: 1,000,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   16 May 2023 
 f)   Place of the              Amman 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Grant of a pledge by Darhold Limited over 1,000,000 
       transaction               Ordinary Shares of 10 pence each in Hikma Pharmaceuticals 
                                 PLC in favour Jordan Kuwait Bank. Darhold Limited 
                                 is defined as a Person Closely Associated with 
                                 the Executive Vice Chairman, who is a director 
                                 and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,000,000 
 d)   Aggregated information    Aggregated volume: 1,000,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   16 May 2023 
 f)   Place of the              Amman 
       transaction 
 

Mohammed 'Ali' Al-Husry

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mohammed 'Ali' Al-Husry 
 2    Reason for the notification 
 a)   Position/status           Non-Executive Director 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Grant of a pledge by Darhold Limited over 1,000,000 
       transaction               Ordinary Shares of 10 pence each in Hikma Pharmaceuticals 
                                 PLC in favour Jordan Kuwait Bank. Darhold Limited 
                                 is defined as a Person Closely Associated with 
                                 the Non-Executive Director, who is a director 
                                 and shareholder of Darhold. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,000,000 
 d)   Aggregated information    Aggregated volume: 1,000,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   16 May 2023 
 f)   Place of the              Amman 
       transaction 
 

Helen Middlemist

Deputy Company Secretary

17 May 2023

+44 (0) 2073992760

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGIGDULUBDGXR

(END) Dow Jones Newswires

May 17, 2023 04:56 ET (08:56 GMT)

Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Hikma Pharmaceuticals (LSE:HIK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024